SATO VICKI L

CIK 000119702011 companiesSAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001197020

Recent Transactions

50 trades

Sale
Vir Biotechnology, Inc.$VIR
Common Stock
2026-03-02$9.50/sh−21,800→ 1,122,591 total
Sale
Vir Biotechnology, Inc.$VIR
Common Stock
2026-03-02$9.98/sh−200→ 1,122,391 total
Exercise/Conversion
Vir Biotechnology, Inc.$VIR
Stock Option (Right to Buy)
2026-02-24−42,377→ 0 total
Exercise/Conversion
Vir Biotechnology, Inc.$VIR
Common Stock
2026-02-24$1.49/sh+42,377→ 1,186,768 total
Sale
Vir Biotechnology, Inc.$VIR
Common Stock
2026-02-24$10.26/sh−200→ 1,144,391 total
Sale
Vir Biotechnology, Inc.$VIR
Common Stock
2026-02-24$9.75/sh−42,177→ 1,144,591 total
Sale
Vir Biotechnology, Inc.$VIR
Common Stock
2026-02-02$7.71/sh−22,000→ 1,144,391 total
Sale
Vir Biotechnology, Inc.$VIR
Common Stock
2026-01-02$5.93/sh−22,000→ 1,166,391 total
Sale
Vir Biotechnology, Inc.$VIR
Common Stock
2025-12-01$6.00/sh−22,000→ 1,188,391 total
Sale
Vir Biotechnology, Inc.$VIR
Common Stock
2025-11-03$5.64/sh−22,000→ 1,210,391 total
Sale
Vir Biotechnology, Inc.$VIR
Common Stock
2025-10-01$5.84/sh−22,000→ 1,232,391 total
Sale
Vir Biotechnology, Inc.$VIR
Common Stock
2025-09-02$4.99/sh−22,000→ 1,254,391 total
Sale
Vir Biotechnology, Inc.$VIR
Common Stock
2025-08-01$4.99/sh−22,000→ 1,276,391 total
Sale
Vir Biotechnology, Inc.$VIR
Common Stock
2025-07-01$5.10/sh−22,000→ 1,298,391 total
Award
Allogene Therapeutics, Inc.$ALLO
Stock Option (Right to buy)
2025-06-18+144,400→ 144,400 total
Award
Vir Biotechnology, Inc.$VIR
Stock Option (Right to Buy)
2025-05-30+16,000→ 16,000 total
Award
Vir Biotechnology, Inc.$VIR
Common Stock
2025-05-30+8,000→ 1,320,391 total
Sale
Vir Biotechnology, Inc.$VIR
Common Stock
2025-01-08$12.52/sh−10,960→ 1,312,391 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2025-01-02$20.91/sh−3,080→ 107,976 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2024-11-07$30.00/sh−1,020→ 111,056 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2024-11-01$27.07/sh−3,080→ 112,076 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2024-09-13$30.00/sh−1,020→ 115,156 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2024-09-03$25.37/sh−100→ 116,176 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2024-09-03$24.99/sh−2,980→ 116,276 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2024-07-01$22.86/sh−100→ 119,256 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2024-07-01$22.12/sh−2,980→ 119,356 total
Award
Allogene Therapeutics, Inc.$ALLO
Stock Option (Right to buy)
2024-06-05+95,541→ 95,541 total
Award
Allogene Therapeutics, Inc.$ALLO
Common Stock
2024-06-05+61,475→ 162,575 total
Award
Denali Therapeutics Inc.$DNLI
Stock Option (right to buy)
2024-05-31+17,901→ 17,901 total
Award
Denali Therapeutics Inc.$DNLI
Common Stock
2024-05-31+5,967→ 122,336 total
Award
Vir Biotechnology, Inc.$VIR
Stock Option (Right to Buy)
2024-05-30+16,000→ 16,000 total
Award
Vir Biotechnology, Inc.$VIR
Common Stock
2024-05-30+8,000→ 1,323,351 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2024-05-15$20.39/sh−1,674→ 116,369 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2024-04-15$18.29/sh−1,666→ 118,043 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2024-03-15$20.10/sh−1,666→ 119,709 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2024-02-15$18.37/sh−1,666→ 121,375 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2024-01-16$18.42/sh−1,666→ 123,041 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2023-12-15$23.39/sh−1,666→ 124,707 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2023-11-15$19.13/sh−1,666→ 126,373 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2023-10-16$20.66/sh−1,666→ 128,039 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2023-09-15$24.35/sh−40→ 129,705 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2023-09-15$23.60/sh−1,626→ 129,745 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2023-08-15$24.30/sh−1,666→ 131,371 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2023-07-17$29.60/sh−1,666→ 133,037 total
Sale
Vir Biotechnology, Inc.$VIR
Common Stock
2023-06-30$24.66/sh−18,000→ 1,315,351 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2023-06-28$29.98/sh−1,114→ 134,703 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2023-06-28$29.55/sh−552→ 135,817 total
Award
Allogene Therapeutics, Inc.$ALLO
Stock Option (Right to Buy)
2023-06-13+23,224→ 23,224 total
Award
Allogene Therapeutics, Inc.$ALLO
Common Stock
2023-06-13+59,649→ 101,100 total
Award
Denali Therapeutics Inc.$DNLI
Stock Option (right to buy)
2023-06-01+12,649→ 12,649 total

Companies

Recent Filings

Address

C/O VIR BIOTECHNOLOGY, INC. 1800 OWENS STREET, SUITE 900

SAN FRANCISCO, CA, 94158

View on SEC.gov